510(k) Report

510(k) · Cleared

Recalled · Class II · 2025

Texium Syringe

K071108510(k) TraditionalCleared May 24, 200735-day reviewClass II21 CFR 880.5860Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cardinal Health, Alaris Products · FMF Syringe, Piston

Cleared on May 24, 2007 as substantially equivalent to K053049 (Cardinal Health, Alaris Products, 2006) and 1 other predicate after a 35-day review. Its family tree reaches back 3 generations to 1988. 11 later devices descend from it. It has been recalled once.

Decided
May 24, 2007
Review
35 days
Class
Class II
Product code
FMF
Recalls
1
Predicates
2

Its longest line of descent runs back 3 generations to K883614 (1988). 8 ancestors in all. 11 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1995: 2 other ancestors2005: 1 other ancestor1997: 1 other ancestor1994: 1 other ancestor2023: 2 descendants cleared2009: 2 descendants cleared2010: 1 descendant cleared2014: 1 descendant cleared2017: 1 descendant cleared2022: 1 descendant cleared2024: 1 descendant cleared2025: 2 descendants clearedK883614 · Cytoguard (R) · Survival Technology, Inc. · 1988K972527 · Phaseal, System for Sealed Handling of Chemotherapeutic Agents · Quality System Consulting · 1997K053049 · Alaris Safety Male Luer · Cardinal Health, Alaris Products · 2006 · recalled1990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 1 other ancestor3 generations back: 3 other ancestors 1 generation forward: 2 descendants2 generations forward: 2 descendants3 generations forward: 1 descendant4 generations forward: 1 descendant5 generations forward: 2 descendants6 generations forward: 1 descendant7 generations forward: 2 descendants K053049 · Alaris Safety Male Luer · Cardinal Health, Alaris Products · 2006 · recalledK972527 · Phaseal, System for Sealed Handling of Chemotherapeutic Agents · Quality System Consulting · 1997K883614 · Cytoguard (R) · Survival Technology, Inc. · 19880+5
  1. Root · 3 generations backK883614 Cytoguard (R)Survival Technology, Inc. · 1988
  2. 2 generations backK972527 Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting · 1997
  3. 1 generation backK053049 Alaris Safety Male LuerCardinal Health, Alaris Products · 2006 · Recalled
  4. This deviceK071108 Texium SyringeCardinal Health, Alaris Products · 2007
  5. Descendant · cites it directly · 9 of its ownK083152 Equashield SystemPlastmed, Ltd. · 2009
  6. Descendant · 2 generations on · 8 of its ownK091389 Equalshield Luer Lock Connector PairPlastmed, Ltd. · 2009
  7. Descendant · 2 generations on · 7 of its ownK101940 Equashield System Protective PlusEquashield Medical, Ltd. · 2010
  8. Descendant · 3 generations on · 6 of its ownK132899 Equashield Closed System Drug Transfer Device (CSTD)Equashield Medical, Ltd. · 2014
  9. Descendant · 4 generations on · 5 of its ownK170706 Equashield Closed System drug Transfer Device (CSTD)Equashield Medical, Ltd. · 2017

Showing 5 of 11 descendants. See all descendants

Descendants cleared per year

2009: 22010: 12014: 12017: 12022: 12023: 22024: 12025: 2
2009high 2 (2009) · low 0 (2011)2026

Most influential descendants

Showing 5 of 11 · See all
  • K083152Equashield SystemPlastmed, Ltd. · 2009 · cites it directly9descendants
  • K091389Equalshield Luer Lock Connector PairPlastmed, Ltd. · 2009 · 2 generations on8descendants
  • K101940Equashield System Protective PlusEquashield Medical, Ltd. · 2010 · 2 generations on7descendants
  • K132899Equashield Closed System Drug Transfer Device (CSTD)Equashield Medical, Ltd. · 2014 · 3 generations on6descendants
  • K170706Equashield Closed System drug Transfer Device (CSTD)Equashield Medical, Ltd. · 2017 · 4 generations on5descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K883614Cytoguard (R)Survival Technology, Inc.1988—
−2K972527Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting1997—
−1K053049Alaris Safety Male LuerCardinal Health, Alaris Products20063
0 (this device)K071108Texium SyringeCardinal Health, Alaris Products2007—
+1K083152Equashield SystemPlastmed, Ltd.2009—
+2K091389Equalshield Luer Lock Connector PairPlastmed, Ltd.2009—
+2K101940Equashield System Protective PlusEquashield Medical, Ltd.2010—
+3K132899Equashield Closed System Drug Transfer Device (CSTD)Equashield Medical, Ltd.2014—
+4K170706Equashield Closed System drug Transfer Device (CSTD)Equashield Medical, Ltd.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199520
199710
200510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200920
201010
201410
201710
202210
202320
202410
202520
FIG. 1 — Lineage of K071108, 1988–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FMF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FMF device

  1. #1 K241821 Luer Lock Syringe with Safety Needle; Luer…score 16.2 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K053049Alaris Safety Male Luer
Summary page 1
…inge is a single use piston syringe that consists of a syringe (3mL, 5mL, 1OmL, 2OmL or 6OmL) permanently bonded to a closed male luer device (TexiumTm Closed Male Luer, K053049). The TeXiumTM Syringe is designed to promote safe handling of fluids and medications, particularly hazardous or cytotoxic drugs.…
Cardinal Health, Alaris Products20063
*K954064Becton Dickinson Syringse
Summary page 2
…049 1/12/06 (originally submitted as the Products Alaris® Safety Male Luer Becton Dickinson Syringe Becton Dickinson & Company K954064 11/21/95 INTENDED USE The TexiumTM Syringe is intended to provide leak-free handling of potentially hazardous fluids,…
Bd Becton Dickinson Vacutainer Systems Preanalytic1995—

Also cleared against K053049: 2 other devices →

What descends from it? (11)

See all 11

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K083152Equashield SystemPlastmed, Ltd.20099
K231888BD Texium™ Needle-Free SyringeCare Fusion20230

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 12, 2025Class IIZ-1971-2025Process controlSterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 3 companies; a new generation was cleared every 8.3 years on median.
  • 3 of the 8 ancestors have a recall of any class.
  • Of its descendants, K083152 (Plastmed, Ltd., 2009) has gone furthest, with 9 descendants of its own.
  • 2 other devices also cite its predicate K053049.

How does its category compare?

All FMF devices

FMF Syringe, Piston: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · FMF

13in 2025

2007: 232008: 92009: 142010: 112011: 162012: 92013: 122014: 132015: 112016: 122017: 132018: 82019: 112020: 152021: 202022: 242023: 222024: 142025: 132026 (partial year): 9
2007high 24 (2022) · low 8 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FMF

114in 2025

2007: 90 days median2008: 74 days median2009: 94 days median2010: 130 days median2011: 109 days median2012: 86 days median2013: 154 days median2014: 84 days median2015: 87 days median2016: 146 days median2017: 135 days median2018: 87 days median2019: 146 days median2020: 107 days median2021: 175 days median2022: 211 days median2023: 173 days median2024: 130 days median2025: 114 days median2026 (partial year): 239 days median
2007high 239 (2026) · low 74 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FMF

19in 2023

2007: 62008: 112009: 152010: 122011: 32012: 62013: 12014: 12015: 22017: 32018: 22019: 12020: 22021: 12022: 22023: 19, 18 Class I2026 (partial year): 2, 1 Class I
2007high 19 (2023) · low 0 (2016)2026

Class I (19 since 2007) Class II/III not classified

Adverse event reports per year · FMF

4,181in 2025

2007: 6742008: 6912009: 9132010: 6792011: 1862012: 3072013: 3262014: 2442015: 2732016: 6842017: 1,8582018: 3,9522019: 5,8632020: 5,3342021: 5,8742022: 5,2332023: 5,2142024: 5,1222025: 4,181
2007high 5,874 (2021) · low 186 (2011)2025

MAUDE reports naming product code FMF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200723906674
200897411691
2009149415913
20101113012679
2011161093186
20129866307
2013121541326
201413841244
201511872273
2016121460684
20171313531,858
201888723,952
20191114615,863
20201510725,334
20212017515,874
20222421125,233
20232217319 (18)5,214
20241413005,122
20251311404,181
202692392 (1)—

What is it indicated for?

The TexiumTM Syringe is indicated for use by healthcare professionals for fluid aspiration/injection, reconstituting, dispensing/ transferring, administering, and disposal of potentially hazardous fluids, such as chemotherapy, radioactive isotopes, and blood products, as well as non-hazardous fluids. The TexiumTM Syringe is intended for use with the SmartSite® Needle Free Valve port or standard open female luers.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K071108: Texium Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K071108

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026